Every SEC Form 3/4/5 on record for this filer (CIK 1005544) — 2 issuers, 22 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Director | 2015-11-13 → 2026-02-25 | 28 | −$2M |
| VTAE | Vitae Pharmaceuticals, Inc | Director · lapsed | 2015-07-02 → 2015-07-10 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| SUPN | 2025-10-09 | Sell | 23,800 | $50.73 | $1M | 105,844 |
| SUPN | 2025-10-09 | Sell | 1,200 | $51.55 | $61,860 | 104,644 |
| SUPN | 2025-08-27 | Sell | 3,588 | $45.01 | $161,496 | 129,644 |
| SUPN | 2025-08-25 | Sell | 1,000 | $45.00 | $45,000 | 133,232 |
| SUPN | 2025-08-22 | Sell | 1,412 | $45.00 | $63,540 | 134,232 |
| SUPN | 2024-11-11 | Sell | 10,700 | $36.24 | $387,768 | 130,275 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.
